PubMed · 8936801
Augmentin reconsidered.
Abstract
The antibiotic co-amoxiclav (Augmentin-SmithKline Beecham) was first launched in the UK in 1981. When we reviewed it in 1982, we recommended it as second-line treatment for urinary infections and concluded that its place in other infections was unclear. Here we reassess the value of co-amoxiclav.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
1996. Augmentin reconsidered.. https://doi.org/10.1136/dtb.1996.341076
Cite the original work for its findings. Save a collection to share your selection of sources.